|
|
|
|
| LEADER |
02892nam a2200373 u 4500 |
| 001 |
EB001839624 |
| 003 |
EBX01000000000000001003613 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 0309304032
|
| 020 |
|
|
|a 9780309304030
|
| 100 |
1 |
|
|a Madhavan, Guruprasad
|e [editor]
|
| 245 |
0 |
0 |
|a Ranking vaccines, Phase III: Use case studies and data framework
|h Elektronische Ressource
|b applications of a prioritization software tool
|c Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase III ; Board on Population Health and Public Health Practice, Board on Global Health ; Guruprasad Madhavan, Charles Phelps, Rino Rappuoli, Rose Marie Martinez, and Lonnie King, editors ; Institute of Medicine and National Academy of Engineering of the National Academies
|
| 246 |
3 |
1 |
|a Use case studies and data framework
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c [2015], 2015
|
| 300 |
|
|
|a 1 PDF file (xiii, 114 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Drug Industry / organization & administration
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Drug Discovery
|
| 653 |
|
|
|a Vaccines / economics
|
| 653 |
|
|
|a Economics, Pharmaceutical
|
| 653 |
|
|
|a Software
|
| 700 |
1 |
|
|a Phelps, Charles E.
|e [editor]
|
| 700 |
1 |
|
|a Rappuoli, Rino
|e [editor]
|
| 700 |
1 |
|
|a Martinez, Rose Marie
|e [editor]
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase III
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 500 |
|
|
|a Title from PDF title page
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK284622
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a SMART Vaccines - Strategic Multi-Attribute Ranking Tool for Vaccines - is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I . The 2013 Phase II report refined a beta version of the model developed in the Phase I report. Ranking Vaccines: Applications of a Prioritization Software Tool: Phase III: Use Case Studies and Data Framework extends this project by demonstrating the practical applications of SMART Vaccines through use case scenarios in partnership with the Public Health Agency of Canada, New York State Department of Health, and the Serum Institute of India. This report also explores a novel application of SMART Vaccines in determining new vaccine product profiles, and offers practical strategies for data synthesis and estimation to encourage the broader use of the software
|